AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06484933 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus groups of health professionals and users of primary care
Description: 2 phases of Focus Group will be organized :~* the participants of the first 4 Focus Groups will propose an operational definition of the notion of a professional team in primary care (validation by consensus based on the definitions in the literature)~* 12 subsequent Focus Groups will be organized in 12 primary care teams to describe the ways in which risks are managed in primary care
Study NCT04909437 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mycobiotic
Description: 2 sachet/day, 21 days, oral
Study NCT04909437 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2 sachet/day, 21 days, oral
Study NCT01819623 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-pharmacological therapy
Description: It consists of a weekly two-hour session. During the first hour yoga classes will taught by teacher, during second hour supervised cognitive training by a psychologist based on Memory Program designed by Memory Unit of Madrid
Study NCT06497153 — intervention group
Intervention type: PROCEDURE
Intervention: lung ultrasound
Description: lung ultrasound repeated according to protocol during the stay in the paediatric intensive care unit
Study NCT06280690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SGM-101
Description: SGM-101 is cea-targeted fluorescent dye
Study NCT04338126 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Description: previously described
Study NCT04338126 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: previously described
Study NCT04926883 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: bulk-fill composite resin restorations
Description: bulk-fill composite resin restorations up to 5mm layer thickness
Study NCT05436756 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Biological sampling and collection
Description: * Biological sampling and collection:~  * whole blood: 1 dry tube for IgG and IgM anti-leptospirosis serology (volume depending on the patient's weight)~ * urine: 1 bottle of 30ml~* Freezing of serum after centrifugation~* Storage~* Collection of clinico-biological data on a dedicated eCRF
Study NCT04862702 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: mechanical instrumentation using rotary file system
Description: the mechanical preparation will be performed using rotary file system
Study NCT04862702 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: mechanical instrumentation using rotary file system
Description: the mechanical preparation will be performed using rotary file system
Study NCT05990478 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Contrast-Enhanced Mammography
Description: Participants will have pre- and post-treatment CEM of the affected breast
Study NCT05990478 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Breast MRI
Description: Pre- and post-NAT breast MRI will be performed for all participants
Study NCT04908332 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Kangaroo Baby Massage
Description: The Kangaroo Baby Massage is an intervention that arose from nursing practice in 1996. It is a therapy that does not require an incubator, fuses massage, kangaroo position and music. KBM is available on video
Study NCT04908332 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Kangaroo Baby Massage
Description: The Kangaroo Baby Massage is an intervention that arose from nursing practice in 1996. It is a therapy that does not require an incubator, fuses massage, kangaroo position and music. KBM is available on video
Study NCT05797558 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Unilateral adrenalectomy
Description: Minimally invasive surgery is performed via the lateral transperitoneal approach or the posterior retroperitoneal approach, with or without robotic assistance, according to the surgeon's preference.
Study NCT05797558 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Medical treatment (eplerenone)
Description: The initial dose of eplerenone is 25 mg twice daily. The dose will be increased by 50 mg every fourth week until systolic blood pressure of 140 mmHg and diastolic blood pressure of 90 mmHg or lower has been reached and biochemical control (plasma renin above the middle of the reference range, i.e > \~20 mIU/L) is attained and/or hyperkalemia develops. The maximal dose of eplerenone is 300 mg twice daily.
Study NCT05836805 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C]XZP-3621
Description: Extemporaneously compounded oral suspension solution of \[14C\]XZP-3621 (400 mg/200 µCi)
Study NCT05745805 — intervention group
Intervention type: DEVICE
Intervention: Simultaneous cortico-spinal magnetic resonance imaging, Serum
Description: Simultaneous cortico-spinal magnetic resonance imaging data were collected in a strong magnetic field and collected the serum of participants.
Study NCT05299047 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group US-guided
Description: An ultrasound system with a 5-2 MHz curved transducer will be used. The division of the abdominal aorta into the common iliac arteries was located using oblique sonography. Then, the transducer will image the body of the fifth lumbar vertebra, at which level bilateral common iliac vessels will be seen leaving a space in the midline. a 20 cm long, 22 gauge Chiba needle will be introduced into the hypogastrium, with out-of-plane technique to access the fifth lumbar vertebral body at its anterior-most point, so that injected drug spreads equally bilaterally along the anterior curvature of the fifth lumbar vertebral body.Suction was applied to the needle to confirm that it was not within a vessel and 10 ml of 50% ethanol will be injected for neurolysis.
Study NCT05299047 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group fluoroscopy-guided
Description: The patient will be placed in the supine position. The L5-S1 inter-discal space was identified under fluoroscopy.After providing local cutaneous and subcutaneous anesthesia with 2% Lignocaine solution nearly 3-4 cm below the umbilicus, a 20 cm long, 22 gauges Chiba needle is advanced to the anterior portion of the 5th vertebral body under ongoing fluoroscopic guidance. Once bony resistance is reached, gently inject 2-5 ml contrast which typical reveals a characteristic triangular blob of contrast with no vascular opacification.Before injection the needle is aspirated to confirm there is no blood. A preliminary test dose of about 3 cc of 0.5% bupivacaine is then injected. If there is no change in heart rate or neurological status, rest of the 20 cc phenol 10% is injected slowly with intermittent aspiration.
Study NCT04840251 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Well-being review and rehabiliation
Description: For their well-being review, patients will meet with a physiotherapist specialist in PH and discuss:~* how they are~* what they can do for themselves~* what it is challenging for them to do~* how active they are~* if they have ever exercised before The physiotherapist will then make a referral to the most suitable rehabilitation service local to the patient e.g. rehabilitation classes, physiotherapy at home, weight-loss programmes.
Study NCT04840251 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Qualitative Interviews
Description: Patients who have previously undergone rehabilitation will take part in a semi-structured interview to explore their experience and the impact it has had
Study NCT05232916 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% Normal Saline
Study NCT05232916 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GLSI-100
Description: 500 mcg/mL GP2 and 125 mcg/mL GM-CSF
Study NCT06404307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-administration
Description: patients will self administer their antimicrobial treatment
Study NCT06551519 — intervention group
Intervention type: OTHER
Intervention: ofatumumab
Description: This is an observational study. There is no treatment allocation. The decision to initiate ofatumumab will be based solely on clinical judgement.
Study NCT06551519 — intervention group
Intervention type: OTHER
Intervention: DMT category 1
Description: This is an observational study. There is no treatment allocation. The decision to continue their current DMT will be based solely on clinical judgement.
Study NCT05543356 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Tozinameran
Description: A single standard dose (30mcg) will be administered on day 0 of the study.
Study NCT05543356 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Elasomeran
Description: A single standard dose (50mcg) of the intervention will be administered on day 0 of the study.
Study NCT05543356 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bivalent Pfizer-BioNTech
Description: A single standard dose (BNT162b2 15μg +BNT162b2 OMI 15μg) will be administered on day 0 of the study.
Study NCT05543356 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bivalent Moderna
Description: A single standard dose (BNT162b2 15μg + BNT162b2 OMI 15μg)will be administered on day 0 of the study.
Study NCT05543356 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bivalent Pfizer-BioNTech
Description: A single standard dose (BNT162b2 15μg + BNT162b2 OMI 15μg) will be administered on day 0 of the study.
Study NCT05543356 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Bivalent Moderna
Description: A single standard dose (BNT162b2 15μg +BNT162b2 OMI 15μg) will be administered on day 0 of the study.
Study NCT06657105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EE/LNG
Description: EE/LNG tablet will be administered orally.
Study NCT06657105 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baxdrostat
Description: Baxdrostat tablet will be administered orally.
Study NCT04820868 — intervention group
Intervention type: DEVICE
Intervention: Multi-cancer early detection test
Description: Blood collection and multi-cancer early detection test
Study NCT05666583 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Art therapy
Description: The intervention group is the group in which art therapy is applied. They receive chemotherapy.
Study NCT05314400 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Full Gadoxetate-enhanced liver MRI
Description: Standard pulse sequences
Study NCT05314400 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Shortened Gadoxetate-enhanced liver MRI
Description: Fewer pulse sequences
Study NCT05031884 — intervention group
Intervention type: DEVICE
Intervention: MGIR3-US
Description: MGIR3-US is an remote scanning robot which can do ultrasonic examinations.
Study NCT05128981 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: MI-CBT
Description: Education of MI and common reactions, Interoceptive exposure, Exposure in-vivo, Behavioral activation, Relapse prevention
Study NCT05017857 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: RepetiveTranscrainal Magnetic Stimulation (rTMS)
Description: RepetiveTranscrainal Magnetic Stimulation (rTMS): rTMS is a non-invasive electromagnetic stimulation of the brain. A train of electric pulses is delivered at the same intensity over a set period of time to a targeted region of the brain. The current stimulates or suppresses neuronal activity based on the frequency and inter-train interval between the pulses.
Study NCT05017857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Problem-Solving Training (PST)
Description: Problem-Solving Training (PST) is a metacognitive strategy training in which patients are guided through a process of conscious self-assessment resulting in problem identification, generation of solutions, development of specific goals and action plans, and evaluation and revision of plans as needed. PST thus helps to circumvent impulsive or unrealistic problem-solving attempts that lead to failure, discouragement, and feelings of helplessness.
Study NCT04995822 — intervention group
Intervention type: DEVICE
Intervention: hip arthroplasty
Description: Hip prosthesis surgery
Study NCT05459727 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Non-surgical periodontal therapy
Description: Non-surgical periodontal therapy includes basic oral hygiene instructions and full-mouth subgingival scaling and root planing under local anesthesia.
Study NCT05459727 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Control periodontal treatment
Description: Control periodontal treatment includes basic oral hygiene instructions and full-mouth supragingival ultrasonic scaling.
Study NCT05593965 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Delta-beta TMS
Description: TMS will be delivered in a delta-beta pattern in which triplets of pulses delivered at 20 Hz (50 milliseconds between each pulse) are sent every 3 Hz (333 milliseconds between the start of each triplet).
Study NCT05593965 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Theta-gamma TMS
Description: TMS will be delivered in a theta-gamma pattern in which triplets of pulses delivered at 50 Hz (20 milliseconds between each pulse) are sent every 5 Hz (200 milliseconds between the start of each triplet).
Study NCT05593965 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Arrhythmic TMS
Description: TMS will be delivered in an arrhythmic pattern in which pulses are delivered with a random inter-pulse interval. The number of pulses and duration is matched to that of the Delta-beta TMS and Theta-gamma TMS.
Study NCT02385396 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Inofolic: myo-inositol and folic acid
Description: 4000 mg of myo-inositol and 0,4 mg of folic acid for 3 months preceding the ICSI procedure
Study NCT04942756 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring
Description: FSL2 is an integrated continuous glucose monitoring (CGM) system that provides continuous glucose measurements every minute to provide glucose levels, trends and alerts. It is composed by a sensor and a reader. The Sensor, to apply on the back of the arm, continuously measures glucose concentration in interstitial fluid and has an 8-hour memory capacity. The Sensor is factory calibrated, does not require finger stick calibration and can be worn for up to 14 days.~The reader is a small handheld device that monitors glucose values in real-time to provide alerts and alarms which, when enabled, warn the user of Low Glucose, High Glucose or Signal Loss and prompt the user to scan the Sensor.~The FSL 2 System is CE mark, it is commercially available and in the current study it is being used in accordance with approved labeling. No modifications of FSL2 System have been performed for the utilization in the current study.
Study NCT04942756 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard Care
Description: The control group is represented by the usual standard way for blood glucose (BG) monitoring. The control group will use a lancing device for finger samples for collection of blood drop to be put in the test strips to be read in the Glucose meter. Lancing devices, lancets and test strips used in the comparison groups are CE marked and are used according to the user's instructions.~Monitoring and/or self-monitoring of blood glucose using glucose meters and test strips provides quantitative measurements of fingerstick blood glucose at a single point in time for patients and their healthcare providers to monitor the effectiveness of glycemic control and make more immediate treatment with the right dosage of insulin. The usual standard routine for blood glucose monitoring in patients with DM and with insulin therapy is represented by at least three finger pricks/die according to the usual standards routine of each center.
Study NCT05613894 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cabozantinib
Description: (177Lu)-PSMA-617 will be administered every 6 weeks for up to 6 cycles per SOC. Oral Cabozantinib taken daily at home.
Study NCT05727137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single shot adductor canal block
Description: Single shot adductor canal block on the the first and second postoperative day.
Study NCT05727137 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous adductor canal block
Description: A catheter will be placed in the adductor canal and connected to a continuous patient-controlled analgesia pump.
Study NCT06248450 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Medical yoga
Description: Medical yoga is a therapeutic form of Kundalini yoga led by a certified yoga instructor that uses different standardized yoga programs with a combination of physical postures, breathingexercises, and relaxation/meditation.
Study NCT05710341 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Water with added nitrate
Description: Water with added nitrate
Study NCT05710341 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Water without added nitrate
Description: Water without added nitrate
Study NCT05134792 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intravenous immunoglobulin
Description: All pediatric burn patients allocated in group intra venous immunoglobulin admitted will receive 200 mg/kg IVIG once after their initial resuscitation before 48 hours passes of burn incident.
Study NCT05128812 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: PLX
Description: Intake of natural food supplement of vegetable origin based on lemon verbena extract (Lippia citriodora). To study the anxiolytic effects in subjects with high perceived stress levels and low sleep quality.
Study NCT05128812 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: PLX
Description: Intake of natural food supplement of vegetable origin based on lemon verbena extract (Lippia citriodora). To study the anxiolytic effects in subjects with high perceived stress levels and low sleep quality.
Study NCT06774898 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Custom-molded lumbar-sacral orthosis
Description: A custom-molded lumbar-sacral orthosis made according to the Vésinet method associated with measures designed to enhance adherence based on goal-setting techniques (i.e. personalized advice, self-determination of the wearing time, hotline) techniques and monitoring of adherence using a temperature sensor chip to provide feedbacks to participants on the wearing time at follow-up visits, and usual care (i.e. a standardized prescription of 20 outpatient physiotherapy sessions including active self-correction, spinal muscle strengthening, spine and lower limb stretching and learning of home-based exercises).
Study NCT06774898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Usual Care
Description: Usual care consisting in a standardized prescription of 20 outpatient physiotherapy sessions including active self-correction, spinal muscle strengthening, spine and lower limb stretching and learning of home-based exercises
Study NCT05570084 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Silodosin
Description: Cap silodosin for medical expulsion therapy
Study NCT05570084 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tamsulosin
Description: Cap tamsulosin
Study NCT05582460 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Reporter Gene Assay
Description: Transcription factor reporter gene assay using luciferase
Study NCT05582460 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Flow Cytometry
Description: Flow Cytometry Analysis using the Sysmex UF-4000, analyzing for bacteria, mononuclear and polymorphonuclear cells, and red blood cell and white blood cell count.
Study NCT05316922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Description: Levothyroxine is used to treat hypothyroidism (low thyroid function). This medicine is given when your thyroid does not produce enough of this hormone on its own.
Study NCT06305416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ranibizumab 10mg/ml Injection
Description: Ranibizumab 10mg/ml Injection (proposed ranibizumab biosimilar) 0.5mg via intravitreal injection every 4 weeks
Study NCT06305416 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lucentis
Description: Lucentis (ranibizumab) 0.5mg via intravitreal injection every 4 weeks
Study NCT04944537 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: No Intervention
Study NCT05888870 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SCT800 and Daratumumab
Description: SCT800 50IU/kg TIW alone or treated with Daratumumab 8mg/kg 4-8 times
Study NCT05888870 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SCT800
Description: SCT800 50IU/kg TIW alone
Study NCT05737992 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise in water
Description: Participants will do some exercises in water for 30-60 minutes. Exercises will be performed at a moderate exercise intensity (12-14 on the Borg Rate of Perceived (RPE) Scale).~All protocols are tailor-made based on each individual's needs and physical abilities.
Study NCT02069626 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: compression time of the laparoscopic linear stapler
Study NCT05339100 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anifrolumab
Description: Participants will receive SC doses anifrolumab via AI or APFS.
Study NCT05339100 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Anifrolumab
Description: Participants will receive SC doses anifrolumab via AI or APFS.
Study NCT05339100 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Autoinjector
Description: Autoinjector will be use to administer single SC dose of anifrolumab.